# Pharmacokinetics and Tolerability of Sulthiame

> **NCT03400189** · PHASE1 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 4 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Sulthiame

## Key facts

- **NCT ID:** NCT03400189
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-12
- **Primary completion:** 2018-05-22
- **Final completion:** 2018-08-30
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2020-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03400189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03400189, "Pharmacokinetics and Tolerability of Sulthiame". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03400189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*